FIGURE 2
The nanotechnology provides extensive and effective nanomaterials and
tools that could be used in the detection and treatment of different
inflammatory disorders and conditions. Some in vitro andin vivo experiments have been performed to examine the impact of
nanoparticles on the development of inflammation and its subsequent
disorders (Kadhim, Karsh, & Jabir,
2020). By modulating the nanoparticles, they can be directed to pass
from the metabolic barriers and deliver drugs to particular targets
without interacting with other cells. This makes them promising
therapeutical candidates as anti-aging drugs that exert their effect by
limiting the local inflammation.
In spite of the therapeutic potential of bioactive nanoparticles in the
treatment of diseases initiated by chronic inflammation, still, further
studies are required to overcome their potential toxicity and identify
their pharmacokinetic properties, such as the least effective
concentrations, physicochemical interactions, route of administration,
etc. (Elsayed & Norredin, 2019). New
advances in nanotechnology and nanomedicine-based strategies have led to
the emergence of nanomedicine for the inflammatory disease treatments
that can be directly effective in delaying aging (Table 6 )
(Rizzuto et al., 2019).